首页|期刊导航|中国临床药理学杂志|药学服务收费政策下肿瘤专科临床药师实施住院药学监护的效果评价

药学服务收费政策下肿瘤专科临床药师实施住院药学监护的效果评价OA

To evaluate the effect of inpatient pharmaceutical care implemented by oncology clinical pharmacists under the policy of pharmaceutical service charging

中文摘要英文摘要

目的 评价药学服务收费政策实施后肿瘤专科临床药师开展住院患者药学监护的实践情况.方法 回顾性分析北京某三甲医院肿瘤科在2024年11月至2025年7月接受收费药学监护患者的病例资料,包括监护内容、监护药品、监护类型及干预情况.结果 共纳入131例患者,月均监护例数14.55例次.共提出药学监护建议361条,其中干预性建议154条(42.66%);药学评估建议207条(57.34%).干预性建议主要为:药物不良反应治疗42条(27.27%),用药方案制定/调整42条(27.27%)等;评估性建议主要为:药物不良反应风险监测103条(49.76%),用药教育67条(32.37%)等.结论 本研究描述了政策落地后的初步实践,可为后续对照研究提供基线,也为实施住院药学监护模式提供新思路.

Objective To evaluate the practice of pharmaceutical care in oncology clinical pharmacists after the implementation of the charging policy for pharmaceutical service.Methods The clinical data of patients who received paid pharmaceutical care in the oncology department of a tertiary hospital in Beijing from November 2024 to July 2025 were retrospectively analyzed,including monitoring content,monitoring drugs,monitoring type and intervention.Results A total of 13 1 patients were enrolled,and the average number of monitored patients was 14.55 per month.A total of 361 pharmaceutical care suggestions were put forward,of which 154(42.66%)were intervention suggestions,of which 207(57.34%)were pharmaceutical evaluation recommendations.The main suggestions for intervention were:42 suggestions for the treatment of adverse drug reactions(27.27%),42 suggestions for the formulation/adjustment of medication regimens(27.27%),etc.The main recommendations included risk monitoring of adverse drug reactions(103 recommendations,49.76%),medication education(67 recommendations,32.37%),etc.Conclusion This study describes the initial practice after the implementation of the policy,which can provide a baseline for subsequent controlled studies and also provide a new idea for the implementation of the model of inpatient pharmaceutical care.

王鑫;魏娆;安卓玲

首都医科大学附属北京朝阳医院药事部,北京 100020首都医科大学附属北京朝阳医院药事部,北京 100020首都医科大学附属北京朝阳医院药事部,北京 100020

医药卫生

药学服务收费临床药师药学监护肿瘤专科

pharmaceutical service chargeclinical pharmacistspharmaceutical carespecialty of cancer

《中国临床药理学杂志》 2026 (2)

254-257,4

10.13699/j.cnki.1001-6821.2026.02.017

评论